Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
Raman Sankar, MD, PhD
Scott Aaronson, MD
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
Optimizing VNS Parameters: Keys to Therapeutic Success
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
FSGS in Practice: Patient-Centered Decision-Making
Kenneth Lieberman, MD
Howard Trachtman, MD, FASN
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
Precision Medicine in IgAN: A Deep Dive Into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
September 19, 2025
Prague
Impact of Barostim on Heart Failure Hospitalization
Jacob Abraham, MD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Silke R. Brix, MD, MRCP, SCPR
Don't Miss It! Rapid & Accurate AAV Diagnosis
Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care
Melissa Magwire, RN, MSN, CDE
Matthew Bullington, PharmD
Dawn M. Denicola, FNP-C
Keith Miller, MD
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
Mazen Hanna, MD